INFINITE ENERGY LLC
STATE UNIVERSITY, AR · Biotech
Genetically engineered corn plants that produce industrial enzymes
infiniteenzymes.com →- Grants
- $955K
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Agriculture · A Prototype Program For Attaining Specialty Crop Non-regulated Status | $80,000 | |
| Federal grant | Department of Agriculture · Formulating New Cellulases For Diverse Markets: Defining Qa Parameters | $100,000 | |
| Federal grant | Department of Agriculture · Formulating New Cellulases For Diverse Markets: Defining Qa Parameters | $450,000 | |
| Federal grant | Department of Agriculture · Seed-based Lipase And Phospholipase Production For Enzymatic Biodiesel | $100,000 | |
| Federal grant | Department of Defense · Phase I · Enzymatic Remediation of PFAS | $49,965 | |
| Federal grant | Department of Agriculture · An Excellent Process To Generate A Biobased Product With Little Environmental Impact Is To Break Down A Single-use Product, Such As Plastic, Into Its Monomers And Reuse Those Monomers To Recreate The Original Product. If Non-biodegradable Plastics Could Be Reused As High-quality Plastics, Positive Impacts On The Environment Could Be Realized. Polyethylene Terephthalate (pet) Is Accumulating In The Environment At A Staggering Rate. Recycling Of Pet Plastics In Current Methods Requires The Melting | $174,897 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3350 | Aethl Bio, Inc. | — | $1.6M |
| 3351 | PRIMORDIAL GENETICS, INC. | — | $1.6M |
| 3352 | RADIA TECHNICAL IMAGING LLC | — | $37K |
| 3353 | INFINITE ENERGY LLC | — | — |
| 3354 | VANGUARD THERAPEUTICS, INC. | — | — |
| 3355 | enGene Holdings | — | — |
| 3356 | Med Aditus Pharmaceuticals, Inc. | — | $5.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.